Showing results (761-770 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|April 4, 2024
Machine Learning-Based Prediction of Stroke in Emergency DepartmentsVida Abedi, Debdipto Misra, Durgesh Chaudhary, et al.
Therapeutic Advances in Neurological Disorders|April 8, 2024
Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and designPeter V Sguigna, Rehana Z Hussain, Annette Okai, et al.
Therapeutic Advances in Neurological Disorders|November 3, 2023
Optimizing treatment persistence in epilepsy: a comparative analysis of combined antiseizure medications with different mechanisms of actionChun-Wei Chang, Wei-En Johnny Tseng, Wey-Ran Lin, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2023
Structural connections of the centromedian nucleus of thalamus and their relevance for neuromodulation in generalized drug-resistant epilepsy: insight from a tractography studyLuigi G Remore, Ziad Rifi, Hiroki Nariai, et al.
Therapeutic Advances in Neurological Disorders|September 4, 2023
Prevalence and risk factors of anxiety and depression in adult patients with epilepsy: a multicenter survey-based studyWenyan Shi, Hanlin Sun, Wei Peng, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2026
Outcomes of mechanical thrombectomy in acute stroke due to primary embolic middle cerebral artery M2 occlusions: a comparison of late versus early windowsHuan Wang, Deren Wang, Elena Zapata-Arriaza, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2026
Economic value of anti-CD20 therapies in multiple sclerosis: a systematic review of cost-effectiveness studiesJohannes Heinemann, Marco Zirkel, Oliver Schoeffski, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2026
Insights into adherence to cladribine tablets in the real world in multiple countries: results from patient support programsJiwon Oh, Mavis Ayer, Raed Alroughani, et al.
Therapeutic Advances in Neurological Disorders|April 10, 2026
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomesStefano Ziccardi, Damiano Marastoni, Pietro Biasi, et al.
Therapeutic Advances in Neurological Disorders|May 1, 2026
Brivaracetam monotherapy in juvenile myoclonic epilepsy: a safety and efficacy evaluationJing-Wen Zuo, Ying-Yue Dai, Wen-Jing Liu, et al.
Pageof 108